Recent breakthroughs in the field of obesity treatment have generated a new candidate known as ALLUVI Retatrutide. This compound is a {highlypotent GLP-1 receptor agonist, formulated to stimulate the effects of natural glucagon-like peptide-1. Retatrutide has website shown significant efficacy in clinical trials, exhibiting significant reductions i